Maravai LifeSciences Holdings, Inc. - Class A common stock — 재무제표 (NASDAQ:MRVI) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 1.92 B2.28 B1.49 B1.01 B770.58 M 총 부채 1.37 B1.38 B697.57 M431.04 M397.87 M 자본금 총액 545.36 M905.24 M789.88 M577.21 M372.71 M 총 부채 및 주주자본 1.92 B2.28 B1.49 B1.01 B770.58 M 총부채 524.59 M522 M518.71 M290.49 M292.74 M 순부채 524.59 M522 M518.71 M290.49 M69.44 M

뉴스

Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable (MRVI)

Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2026 Earnings Call Transcript

Maravai LifeSciences Holdings, Inc. (MRVI) Tops Q1 Earnings and Revenue Estimates

All You Need to Know About Maravai LifeSciences (MRVI) Rating Upgrade to Buy

Baxter International (BAX) Tops Q1 Earnings and Revenue Estimates

Maravai LifeSciences Holdings, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:MRVI) 2026-02-26

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates

마라바이, 비용 절감으로 2025년 4분기 EBITDA 흑자 전환

Maravai Q4 2025 slides: return to positive EBITDA on cost cuts

Maravai Lifesciences earnings beat by $0.03, revenue topped estimates

마라바이 라이프사이언스, 3월 공정가치 경고 후 60% 수익률 달성

Maravai LifeSciences delivers 60% return after March fair value alert